When it comes to investment opportunities, European countries seem to be the most popular choice among investors, based on the recent Milken Institute’s Global Opportunity Index report. Denmark, Sweden, Finland, United States, and United Kingdom are the top five countries that investors find attractive. Denmark secured the top spot in this year’s rankings, excelling in
A recent early-phase trial has revealed an “exciting” response rate among patients with heavily pretreated, platinum-resistant advanced ovarian cancer who were treated with raludotatug deruxtecan (R-DXd). The trial showed promising outcomes, with one complete response and 17 partial responses among 37 evaluable patients who received R-DXd, an antibody drug conjugate (ADC) directed against cadherin 6